Comparison of the cardiotonic response of ouabain, androstan-3-one, 16-dehydroprogesterone, and conjugated estrogens.
Woods
A
A
Department of Pharmacology, St. Louis College of Pharmacy, Missouri 63110.
Martinez
T T
TT
D000818:Animals; D002301:Cardiac Glycosides / Q000494:pharmacology*; D013196:Dihydrotestosterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology*; D066298:In Vitro Techniques; D009200:Myocardial Contraction / Q000187:drug effects*; D010042:Ouabain / Q000494:pharmacology*; D011374:Progesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D011817:Rabbits; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship
D002301:Cardiac Glycosides; D004966:Estrogens, Conjugated (USP); D013196:Dihydrotestosterone; C038097:androstan-3-one; D011374:Progesterone; D010042:Ouabain; C028106:16-dehydroprogesterone